Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.
Government investigations are an ever-present reality for companies operating in FDA-regulated industries. Whether you're in ...
The Cebu Provincial Government has signed a memorandum of agreement with the Department of Science and Technology and the Food and Drugs Administration to improve the quality of products produced by ...
The FDA has issued final guidance aimed at tattoo ink manufacturers, distributors, and packers on preventing microbial ...
The Times of India on MSN5d
Granules India’s Unit V facility in Andhra Pradesh gets US FDA EIR with NAI statusPharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food ...
The "FDA Regulatory Compliance for Drug and Biotech Product Training Course" training has been added to ResearchAndMarkets.com's offering. This course will benefit professionals involved in working ...
Biocon Biologics' Bengaluru unit classified as voluntary action indicated by US FDA: Our Bureau, Bengaluru Thursday, October 31, 2024, 12:15 Hrs [IST] Biocon Biologics said its dr ...
Bengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' Drug ...
Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide integrated services for t ...
The United States Food and Drug Administration has issued "voluntary action ... The American drug regulator's inspection was ...
Drugmaker Granules India has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration ... From April 8-12, the U.S. FDA had conducted a comprehensive pre-approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback